Demographics, clinical information, EVT-related data and outcome data of acute ischemic stroke patients with LVO and MeVO
| Characteristic | |
| Age, years (n=242) | Mean 72 (range 20–101) |
| <60 | 44 (18.1%) |
| 61–80 | 124 (51.2%) |
| >80 | 74 (30.6%) |
| Gender (n=242) | |
| Men | 113 (46.7%) |
| Women | 129 (53.3%) |
| Clot location (n=242) | |
| LVO | 199 (82.2%) |
| MeVO | 43 (17.8%) |
| ASPECTS (n=232) | 8.3 (2–10) |
| 7–10 | 200 |
| 0–6 | 32 |
| r-tPA (n=241) | |
| Yes | 134 (55.6%) |
| No | 107 (44.4%) |
| EVT (n=242) | |
| Yes | 199 (82.2%) |
| No | 43 (17.8%) |
| TICI (n=240) | |
| 3 | 111 (46.3%) |
| 2c | 2 (0.8%) |
| 2b | 56 (23.3%) |
| 2a | 30 (12.5%) |
| 1 | 6 (2.5%) |
| 0 | 35 (14.6%) |
| Successful (2b–3) | 169 (70.4%) |
| Unsuccessful (0–2a) | 71 (29.6%) |
| OTG (n=228) | 270 min (56–1585 min) |
| <6 hours | 151 (66.2%) |
| >6 hours | 77 (33.4%) |
| GTR (n=179) | 38 min (18–58 min) |
| <30 min | 105 (58.7%) |
| >30 min | 74 (41.3%) |
| Post-EVT ICH (n=104/237) | |
| Non-severe | 86 (36.2%) |
| Severe | 18 (7.6%) |
| EVT complications (n=242) | 12 (5.0%) |
| Infarct size (n=237) | |
| None | 20 (8.4%) |
| <1/3 | 139 (58.6%) |
| >1/3 and <2/3 | 34 (14.3%) |
| >2/3 | 44 (18.6%) |
| Baseline mRS (n=80) | |
| Good (0–2) | 74 (92.5%) |
| Disabled (3–5) | 6 (7.5%) |
| Died (6) | 0 |
| Discharge mRS (n=239) | |
| Good (0–2) | 37 (15.5%) |
| Disabled (3–5) | 168 (70.3%) |
| Died (6) | 40 (16.7%) |
| 90-day mRS (n=195) | |
| Good (0–2) | 62 (31.8%) |
| Disabled (3–5) | 70 (35.9%) |
| Died (6) | 63 (32.3%) |
ASPECTS, Alberta Stroke Program Early CT Score; EVT, endovascular thrombectomy; GTR, groin puncture to recanalization time; ICH, intracranial hemorrhage; LVO, large vessel occlusion; MeVO, medium vessel occlusion; mRS, modified Rankin score; OTG, symptom onset to groin puncture time; r-tPA, recombinant tissue plasminogen activator; TICI, Thrombolysis in Cerebral Infarction.